|
|
| Model Number |
TEM1208GL |
| Medical Device Problem Codes |
Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Adhesion(s) (1695); Hypoxia (1918); Muscle Weakness/Atrophy (1967); Pain (1994); Perforation (2001); Electrolyte Imbalance (2196); Distress (2329); Obstruction/Occlusion (2422); Respiratory Failure (2484); Constipation (3274); Unspecified Tissue Injury (4559); Decreased Appetite (4569)
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced emotional distress.Post-operative patient treatment included revision surgery.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: a2, a3a, b2, b5, b7, d4, g4 (pma / 510(k) #), h4, h6 (patient codes, device codes), additional codes.Complaint reportability has been reassessed and is now reportable as a death.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient's attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced emotional distress, adhesions, bowel obstruction, perforation, pain, loss of appetite, core muscle weakness, constipation, respiratory failure, hypoxia, electrolyte imbalance, death.Post-operative patient treatment included revision surgery, small bowel resection, lysis of adhesions, mesh revision, hospice care.Information received indicates the patient is deceased.No information was provided regarding the circumstances of expiration.
|
| |
|
Search Alerts/Recalls
|
|
|